Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2026-02-20 @ 6:04 PM
Study NCT ID:
NCT06661720
Status:
RECRUITING
Last Update Posted:
2025-12-09
First Post:
2024-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Sponsor:
Alliance for Clinical Trials in Oncology
Organization: